906
Views
25
CrossRef citations to date
0
Altmetric
Original Article

Measurement of glycated albumin in serum and plasma by LC-MS/MS

, , &
Pages 195-201 | Received 09 Jun 2015, Accepted 07 Nov 2015, Published online: 22 Feb 2016

References

  • Shi Y, Hu FB. The global implications of diabetes and cancer. Lancet 2014;383:1947–8.
  • Peters SA, Huxley RR, Woodward M. Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. Lancet 2014;383:1973–80.
  • Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia 2014;57:1542–51.
  • El Nahas M. The global challenge of chronic kidney disease. Kidney Int 2005;68:2918–29.
  • Mosca A, Lapolla A, Gillery P. Glycemic control in the clinical management of diabetic patients. Clin Chem Lab Med 2013;51:753–66.
  • Freedman BI. A critical evaluation of glycated protein parameters in advanced nephropathy: a matter of life or death: time to dispense with the hemoglobin A1C in end-stage kidney disease. Diabetes Care 2012;35:1621–4.
  • Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, Burkart JM, Cardona CY, Andries L, Peacock TP, Sabio H, Byers JR, Russell GB, Bleyer AJ. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Periton Dialysis Int 2010;30:72–9.
  • Little RR, Rohlfing CL, Tennill AL, Hanson SE, Connolly S, Higgins T, Wiedmeyer CE, Weykamp CW, Krause R, Roberts W. Measurement of Hba(1C) in patients with chronic renal failure. Clin Chim Acta 2013;418:73–6.
  • Meyer L, Chantrel F, Imhoff O, Sissoko A, Serb L, Dorey F, Fleury D, Smagala A, Kepenekian L, Krummel T, Le Floch JP, Kessler L. Glycated albumin and continuous glucose monitoring to replace glycated haemoglobin in patients with diabetes treated with haemodialysis. Diabetic Med 2013;30:1388–9.
  • Murea M, Moran T, Russell GB, Shihabi ZK, Byers JR, Andries L, Bleyer AJ, Freedman BI. Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis. Am J Nephrol 2012;36:488–96.
  • Nagayama H, Inaba M, Okabe R, Emoto M, Ishimura E, Okazaki S, Nishizawa Y. Glycated albumin as an improved indicator of glycemic control in hemodialysis patients with type 2 diabetes based on fasting plasma glucose and oral glucose tolerance test. Biomed Pharmacother 2009;63:236–40.
  • Peacock TP, Shihabi ZK, Bleyer AJ, Dolbare EL, Byers JR, Knovich MA, Calles-Escandon J, Russell GB, Freedman BI. Comparison of glycated albumin and hemoglobin A(1c) levels in diabetic subjects on hemodialysis. Kidney Int 2008;73:1062–8.
  • Parrinello CM, Selvin E. Beyond HbA1c and glucose: the role of nontraditional glycemic markers in diabetes diagnosis, prognosis, and management. Curr Diabetes Rep 2014;14:548
  • Cohen MP. Perspective: measurement of circulating glycated proteins to monitor intermediate-term changes in glycaemic control. Eur J Clin Chem Clin Biochem 1992;30:851–9.
  • Guthrow CE, Morris MA, Day JF, Thorpe SR, Baynes JW. Enhanced nonenzymatic glucosylation of human serum albumin in diabetes mellitus. Proc Natl Acad Sci USA 1979;76:4258–61.
  • Takahashi S, Uchino H, Shimizu T, Kanazawa A, Tamura Y, Sakai K, Watada H, Hirose T, Kawamori R, Tanaka Y. Comparison of glycated albumin (GA) and glycated hemoglobin (HbA1c) in type 2 diabetic patients: usefulness of GA for evaluation of short-term changes in glycemic control. Endocr J 2007;54:139–44.
  • Anguizola J, Matsuda R, Barnaby OS, Hoy KS, Wa C, Debolt E, Koke M, Hage DS. Review: Glycation of human serum albumin. Clin Chim Acta 2013;425:64–76.
  • Paroni R, Ceriotti F, Galanello R, Battista Leoni G, Panico A, Scurati E, Paleari R, Chemello L, Quaino V, Scaldaferri L, Lapolla A, Mosca A. Performance characteristics and clinical utility of an enzymatic method for the measurement of glycated albumin in plasma. Clin Biochem 2007;40:1398–405.
  • Strader MB, Tabb DL, Hervey WJ, Pan C, Hurst GB. Efficient and specific trypsin digestion of microgram to nanogram quantities of proteins in organic-aqueous solvent systems. Anal Chem 2006;78:125–34.
  • Larssen E, Brede C, Hjelle AB, Oysaed KB, Tjensvoll AB, Omdal R, Ruoff P. A rapid method for preparation of the cerebrospinal fluid proteome. Proteomics 2015;15:10–15.
  • Brede C. Method for the preparation of monolithic columns. Patent WO 2014/029869.
  • Frolov A, Hoffmann R. Identification and relative quantification of specific glycation sites in human serum albumin. Anal Bioanal Chem 2010;397:2349–56.
  • Gadgil HS, Bondarenko PV, Treuheit MJ, Ren D. Screening and sequencing of glycated proteins by neutral loss scan LC/MS/MS method. Anal Chem 2007;79:5991–9.
  • Garlick RL, Mazer JS. The principal site of nonenzymatic glycosylation of human serum albumin in vivo. J Biol Chem 1983;258:6142–6.
  • Lapolla A, Fedele D, Reitano R, Arico NC, Seraglia R, Traldi P, Marotta E, Tonani R. Enzymatic digestion and mass spectrometry in the study of advanced glycation end products/peptides. J Am Soc Mass Spectr 2004;15:496–509.
  • Ueda Y, Matsumoto H. Recent topics in chemical and clinical research on glycated albumin. J Diabetes Sci Technol 2015;9:177–82.
  • Kisugi R, Kouzuma T, Yamamoto T, Akizuki S, Miyamoto H, Someya Y, Yokoyama J, Abe I, Hirai N, Ohnishi A. Structural and glycation site changes of albumin in diabetic patient with very high glycated albumin. Clin Chim Acta 2007;382:59–64.
  • Frolov A, Bluher M, Hoffmann R. Glycation sites of human plasma proteins are affected to different extents by hyperglycemic conditions in type 2 diabetes mellitus. Anal Bioanal Chem 2014;406:5755–63.
  • Inoue K, Tsujimoto T, Yamamoto-Honda R, Goto A, Kishimoto M, Noto H, Kajio H, Doi S, Miyazaki S, Terauchi Y, Noda M. A newer conversion equation for the correlation between HbA1c and glycated albumin. Endocr J 2014;61:553–60.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.